K
56
-4
PYPL
56
-6
PEP
50
2
RIG
50
6
ADSK
70
-4
AVGO
30
-5
BMY
63
2
NKE
31
-2
NWL
50
-6
KO
42
-2
HP
37
-8
ALL
48
-2
BF.B
32
3
EW
29
-3
CME
58
-4
APD
54
2
NRG
47
-3
CI
48
-4
TGT
50
-2
AON
52
-8
K
56
-4
PYPL
56
-6
PEP
50
2
RIG
50
6
ADSK
70
-4
AVGO
30
-5
BMY
63
2
NKE
31
-2
NWL
50
-6
KO
42
-2
HP
37
-8
ALL
48
-2
BF.B
32
3
EW
29
-3
CME
58
-4
APD
54
2
NRG
47
-3
CI
48
-4
TGT
50
-2
AON
52
-8
Financhill
Back

Evoke Pharma Stock Price Chart

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Sell
17

EVOK
Evoke Pharma

Last Price:
4.56
Seasonality Move:
12.83%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVOK is experiencing slight selling pressure.

Evoke Pharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.25 Sell
20-day SMA: 5.56 Sell
50-day SMA: 5.07 Sell
200-day SMA: 6.07 Sell
8-day EMA: 5.06 Sell
20-day EMA: 5.34 Sell
50-day EMA: 5.29 Sell
200-day EMA: 7.33 Sell

Evoke Pharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 35.88 Sell
Chaikin Money Flow: -25306 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.9 - 6.06) Sell
Bollinger Bands (100): (4.53 - 6.19) Sell

Evoke Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Evoke Pharma Stock

Is Evoke Pharma Stock a Buy?

  • Evoke Pharma share price is 4.37 while EVOK 8-day simple moving average is 5.25, which is a Sell signal.
  • The stock price of EVOK is 4.37 while Evoke Pharma 20-day SMA is 5.56, which makes it a Sell.
  • Evoke Pharma 50-day simple moving average is 5.07 while EVOK share price is 4.37, making it a Sell technically.
  • EVOK stock price is 4.37 and Evoke Pharma 200-day simple moving average is 6.07, creating a Sell signal.

EVOK Technical Analysis vs Fundamental Analysis

Sell
17
Evoke Pharma (EVOK) is a Sell

Is Evoke Pharma a Buy or a Sell?

  • Evoke Pharma stock is rated a Sell
    The current Evoke Pharma [EVOK] share price is $4.37. The Score for EVOK is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.

Evoke Pharma Stock Info

Market Cap:
6.49M
Price in USD:
4.37
Share Volume:
51.16K

Evoke Pharma 52-Week Range

52-Week High:
17.40
52-Week Low:
3.54
Sell
17
Evoke Pharma (EVOK) is a Sell

Evoke Pharma Share Price Forecast

  • What is the Evoke Pharma stock price today?
    The Evoke Pharma stock price is 4.37 USD today.
  • Will EVOK stock go up or go down?
    Evoke Pharma> share price is forecast to RISE/FALL based on technical indicators
  • Is Evoke Pharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Evoke Pharma is overvalued.

Is Evoke Pharma Stock a Buy?

  • Evoke Pharma share price is 4.37 while EVOK 8-day exponential moving average is 5.06, which is a Sell signal.
  • The stock price of EVOK is 4.37 while Evoke Pharma 20-day EMA is 5.34, which makes it a Sell.
  • Evoke Pharma 50-day exponential moving average is 5.29 while EVOK share price is 4.37, making it a Sell technically.
  • EVOK stock price is 4.37 and Evoke Pharma 200-day simple moving average is 7.33, creating a Sell signal.

Fundamental Analysis of Evoke Pharma

Is Evoke Pharma a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.

Technical Analysis of Evoke Pharma

Should I short Evoke Pharma stock?

* Evoke Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.